Wisconsin Participates in START Trial
May 17, 2011
Researchers from the Medical College of Wisconsin are taking part in Phase IV of the international Strategic Timing of Antiretroviral Treatment clinical trial, which seeks to determine the best time for asymptomatic persons with HIV to begin taking medications. The study, called START, has a goal of enrolling 4,000 HIV-positive men and women in 30 nations. For more information, visit www.mcw.edu/publicaffairs/NewsCenter/CollegeNews/ResearcherstoparticipateinglobalAIDSclinicaltrial.htm.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)